Коронавирус и другие пандемии.

Цитата: Д. Петров от 10.12.2021 12:16:45Обелять наших не буду, но у ВОЗ первое слово "дорого". Наши говорят о 19%. ВОЗ проценты не упоминает. Может 19% именно бесполезно, но я бы предпочёл хоть 19%.

Скрытый текст

1-я страница

Цитата- сильная рекомендация не применять плазму в период выздоровления у пациентов с нетяжелым COVID-19 (опубликовано 7 декабря 2021 г.);
- сильная рекомендация не использовать плазму выздоравливающих пациентов с тяжелым или критическим COVID-19, кроме как в контексте клинического исследования (опубликовано 7 декабря 2021 г.);

https://www.who.int/…ics-2021.4

Цитата: Д. Петров от 10.12.2021 12:16:45Обелять наших не буду, но у ВОЗ первое слово "дорого". Наши говорят о 19%. ВОЗ проценты не упоминает. Может 19% именно бесполезно, но я бы предпочёл хоть 19%.

ЦитатаWe found 13 studies with 48,509 participants that investigated convalescent plasma. All but one of the studies included participants with moderate to severe COVID-19. We did not find any studies that investigated hyperimmune immunoglobulin. Studies mainly took place in hospitals, in countries all over the world.

ЦитатаModerate to severe COVID-19
Convalescent plasma compared to placebo or standard care:
• convalescent plasma makes no difference to deaths from any cause at up to 28 days after treatment. About 237 in 1000 people given placebo or standard care died, compared to 233 in 1000 people who had been given convalescent plasma (7 studies, 12,646  people);
• convalescent plasma makes little to no difference to the improvement of patients’ condition in terms of needing less breathing support for the overall population needing any breathing support before the start of treatment (8 studies, 12,682 people), and also not for the people that were ventilated at the beginning of the study (2 studies, 630 people);
• convalescent plasma makes no difference to the worsening of patients’ condition. About 126 in 1000 people given placebo or standard care needed invasive mechanical ventilation, compared to 123 in 1000 people who had been given convalescent plasma (4 studies, 11,765 people);
• convalescent plasma may make no difference to unwanted effects. The 8 studies that reported unwanted effects measured and reported their results very differently, so we are unable to draw any conclusions.